Abstract
Purpose
Examination of the mitochondrial mRNA expression in granulosa cells from an unspecified population of infertile patients to evaluate whether recombinant follicle stimulating hormone (recFSH) is more effective in producing higher quality embryo rates compared with human menopausal gonadotropin (hMG).
Method
Thirty-nine patients who underwent the in vitro fertilization and embryo transfer program were retrospectively examined. Patients were administered recFSH (n = 18) or hMG (n = 20) in a long protocol where GnRH agonist was used. Granulosa cells were obtained during oocyte retrieval and examined for mitochondria mRNA expression ratio against GAPDH. Expressions of mitochondria mRNA were evaluated by real-time PCR analysis.
Results
The high-quality embryo rate in the hMG cycle was higher than in the recFSH cycle, and the total dose of hMG showed a positive correlation with the expression level of mitochondrial genes in granulosa cells. Moreover, mitochondria mRNA expression was higher in the hMG cycle than in the recFSH cycle.
Conclusions
Compared with recFSH, hMG induces a higher mitochondrial gene expression ratio in granulosa cells at the time of oocyte retrieval and, therefore, may lead to higher quality embryo rates.
Similar content being viewed by others
References
Hseih RH, Au HK, Yeh TS, Chang SJ, Cheng YF, Tzeng CR. Decreased expression of mitochondorial genes in human unfertilized oocytes and arrested embryos. Fertil Steril. 2004;81:912–8.
Cummins JM. The role of maternal mitochondoria during oogenesis, fertilization and embryogenesis. Reprod Biomed Online. 2002;4:176–82.
Giampietro F, Sancilio S, Tiboni GM, Rana RA, Pietro RD. Levels of apoptosis in human granulose cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist. Fertil Steril. 2006;85:412–9.
Phy J, Stocco DM, Prien SD. Differences in steroidogenic acute regulatory protein expression from the lutenizing-granulosa cells of patients undergoing in vitro fertilization with embryo transfer: implications for cycle outcomes. Am J Obstet Gynecol. 2002;186:872–5.
Depalo R, Nappi L, Loverro G, Bettocchi S, Crauso ML, Valentini AM, et al. Evidence of apoptosis in human primordial and primary follicles. Hum Reprod. 2003;18:2678–82.
Seifer DB, Gardiner AC, Ferreria KA, Peluso JJ. Apoptosis as a function of ovarian reserve in women undergoing in vitro fertilization. Fertil Steril. 1996;66:593–8.
Trounce I, Byme E, Marzuki S. Decline in skeletal muscle mitochondorial respiratory chain function: possible factor in aging. Lancet. 1989;1:637–9.
Cortopassi GA, Amheim N. Detection of a specific mitochondorial DNA deletion in tissue of older humans. Nucleic Acid Res. 1990;18:6927–33.
Baker VL, Fujimoto VY, Kettel LM, Adamson GD, Hoehler F, Jones CE, Soules MR. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers understanding controlled ovarian hyperstimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial. Fertil Steril. 2009;91:1005–11.
Olivieto P, Homburg R, Meltcer S, Rabinson J, Anteby EY, Nahum R. HMG improves IVF outcome in patients with high basal FSH/LH ratio: a preliminary study. Reprod Biomed Online. 2009;18:205–8.
Yamashita Y, Ueda M, Yamashita H, Terai Y, Takehara M, Ueki M. Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells under controlled ovarian hyperstimulation for IVF-ET. Fertil Steril. 2002;78:865–71.
Veeck LL. Oocyte assessment and biological performance. Ann N Y Acad Sci. 1988;541:259–74.
Toya M, Saito H, Ohta N, Saito T, Kaneko T, Hiroi M. Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril. 2000;73:344–50.
De Leeuw R, Mulders J, Voortman G, Damm J, Kloosterboer L. Structure–function relationship of recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod. 1996;2:361–9.
Out HJ, Driessen SGA, Mannaerts BMJL, Coelingh Bennink HJ. Recombinant follicle-stimulating hormone (follicle beta, Puregon) yields higher pregnancy rates in vitro fertilization than urinary gonadotropins. Fertil Steril. 1998;69:40S–4S.
Mannaerts B, Shoham Z, SchootD, Bouchard P, Harlin J, Fauser B, Jacobs H, Rombout F, Coelingh Bennink H. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489) in gonadotropin-deficient volunteers. Fertil Steril. 1998;69(Suppl 1):15S–20S.
Padmanabhan V, Lang LL, Sonstein J, Kelch RP, Beitins IZ. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis. J Clin Endocrinol Metab. 1988;67:465–73.
Al-Inany HG, Abou-Setta AM, Mansour RT. Efficacy and safety of highly purified hMG vs. recombinant follicle stimulating hormone: a meta-analysis. Fertil Steril. 2007;88(Suppl 1):S35–6.
Bayram N, van Wely M, van der Veen F. Recombinant FSH versus urinary gonadotoropins or recombinant FSH for ovulation induction in subfertilty associated poly cystic ovarian syndrome. Cochrane Database Syst Rev. 2001;2:CD002121.
Grandohl ML, Bourp R, Lee Y, Myrhøj V, Meinertz H, Sørensen S. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle stimulating hormone or highly purified human menopausal gonadotoropin. Fertil Steril. 2009;91:1820–30.
Bentov Y, Esfandiari N, Burstein E, Casper RF. The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients. Fertil Steril. 2010;93:272–5.
Nakahara K, Saito T, Ito M, Ohta N, Sakai N, Tezuka N, Hiroi M, Watanabe H. Incidence of apoptotic bodies in membrane granulose of patients participating in an in vitro fertilization program. Fertil Steril. 1997;67:297–303.
Oesterhuis GJE, Michgelesen HW, Lambalk CB, Schoemaker J, Vermes I. Apoptotic cell death in human granulose-lutein cells: a possible indicator of in vitro fertilization outcome. Fertil Steril. 1998;70:747–9.
Yamashita Y, Asano Y, Morishima S, Fujino K, Terai Y, Ohmichi M. Mitochondrial gene expression in granulosa cells of severe endometriosis with in vitro fertilization and embryo transfer. Fertil Steril. 2007;88:1703–5.
Fatum M, Natalie YO, David S, Joseph O, Simon A, Laufer N. Levels of steroidogenic acute regulatory protein and mitochondrial membrane potential in granulosa cells of older poor-responder women. Fertil Steril. 2009;91:220–4.
Lin DPC, Huang CC, Wu HM, Cheng TC, Chen CI, Lee MS. Comparison of mitochondorial DNA contents in human embryos with good or poor morphology at the 8-cell stage. Fertil Steril. 2004;81:73–9.
Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel lutenizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. J Biol Chem. 1994;269:28314–22.
Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC. Lower apoptosis rate in human cumulous cells after administration of recombinant lutenizong hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril. 2007;87:542–6.
Acknowledgment
We have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Saito, N., Yamashita, Y., Ono, Y. et al. Difference in mitochondrial gene expression in granulosa cells between recombinant FSH and hMG cycles under in vitro fertilization and transfer. Reprod Med Biol 12, 99–104 (2013). https://doi.org/10.1007/s12522-013-0147-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12522-013-0147-z